Log in to save to my catalogue

Neurofibromin and suppression of tumorigenesis: beyond the GAP

Neurofibromin and suppression of tumorigenesis: beyond the GAP

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9063229

Neurofibromin and suppression of tumorigenesis: beyond the GAP

About this item

Full title

Neurofibromin and suppression of tumorigenesis: beyond the GAP

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2022-02, Vol.41 (9), p.1235-1251

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disease and one of the most common inherited tumor predisposition syndromes, affecting 1 in 3000 individuals worldwide. The
NF1
gene encodes neurofibromin, a large protein with RAS GTP-ase activating (RAS-GAP) activity, and loss of
NF1
results in increased RAS signaling. Ne...

Alternative Titles

Full title

Neurofibromin and suppression of tumorigenesis: beyond the GAP

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9063229

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9063229

Other Identifiers

ISSN

0950-9232,1476-5594

E-ISSN

1476-5594

DOI

10.1038/s41388-021-02156-y

How to access this item